August 29, 2016 – On August 25, 2016, the Patent Trial and Appeal Board granted Petitioner Instradent USA, Inc.’s request to authorize the deposition of its Reply Declarant to take place via videoconference because the declarant was a third-party witness, who lived in Israel and whose testimony was limited to the facts and circumstances sworn to in his two page declaration. The patent-at-issue is U.S. Patent No. 8,714,977, entitled “Condensing Skeletal Implant that Facilitate Insertions.”
The case is captioned Instradent USA, Inc. v. Nobel BioCare Services AG, Case IPR2015-01786.
By: Giancarlo L. Scaccia